Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit your nominations for the Fierce Innovation Awards - Entries close this Friday
cancer therapies
MedTech
Natera teams with Angiex on cancer drug trial monitoring
Natera inked a deal with biotech Angiex to assess its Signatera blood test, which detects traces of cancer DNA in patients treated for the disease.
Joseph Keenan
Aug 31, 2026 5:56pm
JPM24: Caris crafts collabs with AbbVie, Flatiron Health
Jan 9, 2024 3:34pm
Boehringer buys bacterial cancer therapy biotech in $500M deal
Nov 22, 2023 10:21am
Leal Health adds FDA-approved cancer treatment decision support
Jun 22, 2023 4:30am
Bayer opens new $140M cancer research center in US
Jun 29, 2022 11:05am
New target uncovered for hard-to-treat cancers
Jun 6, 2022 12:07pm